Litcius/Paper detail

Heterologous booster response after inactivated virus BBIBP-CorV vaccination in older people

Santiago Oviedo Rouco, Pamela Elizabeth Rodríguez, Esteban Miglietta, Pablo Rall, María Mora González López Ledesma, Augusto Varese, Carla A. Pascuale, Diego Ojeda, Bianca Mazzitelli, Lautaro Sánchez, Ana Ceballos, Eduardo A. Pérez, Jorge Geffner, Yanina Miragaya, Andrés H. Rossi, Andrea V. Gamarnik

2022The Lancet Infectious Diseases13 citationsDOIOpen Access PDF

Topics & Concepts

VaccinationBooster doseHeterologousMedicineBooster (rocketry)VirologyVaccination scheduleInactivated vaccinePopulationVirusImmunologyImmune systemBiologyImmunizationPhysicsTiterEnvironmental healthAstronomyGeneBiochemistrySARS-CoV-2 and COVID-19 ResearchVaccine Coverage and HesitancyCOVID-19 Clinical Research Studies
Heterologous booster response after inactivated virus BBIBP-CorV vaccination in older people | Litcius